Search Results

Search results for clinical governance

201. blood_group_genotyping_-_neil_avent.pdf

kenneth goldsmith award lecture 2013 blood group genotyping gen2phen finally arrived neil avent head school biomedical healthcare sciences october 17th 2013 disclosure member transfusion medicine advisory board grifols sa conventional blood grouping mixing washed red blood cells blood group specific antibodies monoclonal polyclonal specificities available limited test 100 years karl landsteiner 1901 nobel laureate throughout eu routine blood group serology focussed detection major clinically sig

202. divergent_in_vitro_inflammatory_responses_to_antibodies_relevant_to_transfusion-related_acute_lung_injury_-_john-paul_tung.pdf

divergent vitro inflammatory responses antibodies relevant transfusion related acute lung injury john paul tung wesley bierman christine knauth robert flower melinda dean bbts annual meeting 2013 what transfusion related acute lung injury trali severe potentially fatal reaction 295 cases 45 fatalities uk 1996 2012 1 2 172 fatalities us 2005 2012 3 4 133 trali cases australia 2006 june 2011 5 considered under diagnosed under reported 6 mortality rate 5 10 7 may high 40 icu patients 8 clinical dia

203. pathogeninactivationofplatelets-jean-claudeosselaer.pdf

pathogen inactivation platelets overview 10 years clinical experience jean claude osselaer md jd ets de mont godinne universit catholique de louvain belgium bbts birmingham october 17 2013 rationale pathogen inactivation platelets existing techniques practical experience conclusions confirmed positive cultures 1 400 1 200 per million 1 000 800 600 400 200 0 aerobic aerobic an aerobic 4 ml 8ml 4 4ml diversion 686 234 an aerobic 7 7 7 5ml 845 312 d 1 d d d d m ur ph y er er s e e p eder et al tran

204. rbc_pathogen_reduction_-_dr_jose_cancelas.pdf

rbc pathogen reduction current status trends safer transfusion jose a cancelas md phd hoxworth blood center division experimental hematology cchmc university cincinnati medical center 2013 bbts meeting birmingham uk oct 17th 2013 relevant funding disclosures nih nhlbi us dod veteran affairs cerus co studies s 303 terumo bct studies mirasol macopharma studies p capt hemerus hemonetics solx as 7 studies intellectual property rights a paid consultant shareholder of companies current problems blood

205. tisfortrauma-andyeynon.pdf

t trauma dr andy eynon director major trauma university hospital southampton oct 2013 major trauma leading cause death 40 years baker 1980 trunkey 1983 preview haemorrhage control early surgery early blood blood blood products damage control surgery haemorrhage control patient handling splintage external haemorrhage control tranexamic acid temperature control patient handling 5100 vs 1700 splintage external haemorrhage control txa avoid hypothermia early surgery earlier blood blood products more